Stock listing

NASDAQ:TIL Instil Bio, Inc. Stock

Home listing (NASDAQ) of Instil Bio, Inc.

Follow Instil Bio, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:TIL

$5.23 USD -0.20 (-3.7%)

Close on Nov 20, 2026

Past year -56.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$5.20 – $5.65 USDNov 20, 2026
Volume
64,336 sharesNov 20, 2026
Market cap
$35.47M USDAt the close on Nov 20, 2026 · price × 6.78M shares outstanding
52-week range
$5.14 – $13.50 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$256,706 USDMedian day 25,173 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Instil Bio, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TIL · Home$5.23 USD-0.20 (-3.7%)64,336$5.45$5.65$5.20$5.43Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TIL · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.23-0.20-3.7%$5.45$5.65$5.2064,336
$5.43+0.03+0.6%$5.36$5.63$5.33119,802
$5.40-0.35-6.1%$5.64$5.73$5.14164,635
$5.75-0.33-5.4%$6.02$6.075$5.28138,888
$6.08-0.16-2.6%$6.202$6.495$6.0251,629
$6.24-0.07-1.1%$6.33$6.63$6.1096,317
$6.31-0.04-0.6%$6.35$6.60$6.2353,338
$6.35-0.12-1.9%$6.42$6.86$6.34322,727
$6.47-0.36-5.3%$6.81$6.99$6.3832,674
$6.83-0.16-2.3%$6.72$6.98$6.30107,046
$6.990.000.0%$6.85$7.125$6.7092,543
$6.99+0.32+4.8%$6.74$7.10$6.59675,590
$6.67+0.12+1.8%$6.745$6.805$6.6025,281
$6.55-0.25-3.7%$6.73$6.91$6.5133,865
$6.80-0.025-0.4%$6.74$6.87$6.5125,228
$6.825+0.035+0.5%$6.71$7.12$6.7157,660
$6.79+0.95+16.3%$5.85$6.93$5.85149,610
$5.84+0.27+4.8%$5.56$6.08$5.56102,053
$5.57-0.27-4.6%$5.86$5.88$5.5736,689
$5.84+0.14+2.5%$5.76$5.90$5.66121,348
$5.70-0.07-1.2%$5.80$5.94$5.6884,883
$5.77-0.17-2.9%$6.01$6.09$5.7340,868
$5.94+0.15+2.6%$5.88$6.19$5.85100,161
$5.79-0.12-2.0%$5.89$6.35$5.62147,895
$5.91-0.22-3.6%$6.18$6.45$5.9125,173
$6.13+0.18+3.0%$6.08$6.495$6.0833,024
$5.95-0.23-3.7%$6.06$6.22$5.9344,119
$6.18-0.40-6.1%$6.611$6.611$6.02527,606
$6.58-0.16-2.4%$6.65$6.66$6.5111,333
$6.74+0.18+2.7%$6.69$6.76$6.5337,620
$6.56-0.34-4.9%$6.84$6.895$6.4154,498
$6.90+0.015+0.2%$6.89$7.00$6.857,273
$6.885-0.065-0.9%$7.22$7.22$6.8224,191
$6.95-0.27-3.7%$7.22$7.35$6.9512,944
$7.22-0.015-0.2%$7.19$7.44$7.1528,551
$7.235-0.005-0.1%$7.15$7.30$7.135,201
$7.24+0.10+1.4%$7.19$7.385$7.148,701
$7.14+0.10+1.4%$7.04$7.23$7.044,130
$7.04-0.13-1.8%$7.115$7.16$7.0311,568
$7.17+0.05+0.7%$7.05$7.17$7.059,505
$7.12-0.115-1.6%$7.14$7.24$7.058,361
$7.235+0.105+1.5%$7.03$7.38$7.0311,584
$7.13+0.06+0.8%$7.02$7.20$7.0023,893
$7.07-0.02-0.3%$7.09$7.20$6.9269,053
$7.09-0.12-1.7%$7.13$7.21$7.0827,516
$7.21+0.03+0.4%$7.305$7.399$7.1011,683
$7.18-0.03-0.4%$7.29$7.29$7.168,532
$7.21-0.24-3.2%$7.46$7.46$7.2117,341
$7.45+0.07+0.9%$7.36$7.64$7.3622,440
$7.38+0.02+0.3%$7.32$7.67$7.3233,973
$7.36-0.22-2.9%$7.54$7.70$7.3611,375
$7.58-0.24-3.1%$7.66$7.70$7.507,839
$7.82+0.24+3.2%$7.58$7.82$7.506,281
$7.58-0.08-1.0%$7.59$7.64$7.583,011
$7.66-0.025-0.3%$7.71$7.78$7.5856,456
$7.685-0.005-0.1%$7.73$7.79$7.673,882
$7.69+0.08+1.1%$7.71$7.81$7.5911,900
$7.61+0.03+0.4%$7.56$7.69$7.542,601
$7.58-0.28-3.6%$7.79$7.83$7.4514,491
$7.86+0.03+0.4%$7.685$7.875$7.608,285
$7.83+0.23+3.0%$7.745$7.89$7.6210,692
$7.60-0.21-2.7%$7.75$7.88$7.605,377
$7.81+0.23+3.0%$7.72$7.81$7.6012,789
$7.58+0.15+2.0%$7.40$7.88$7.409,204
$7.43+0.04+0.5%$7.32$7.483$7.323,173

Splits

1 split · NASDAQ:TIL · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
Ticker
NASDAQ:TIL
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Instil Bio, Inc. news

Instil Bio, Inc. on 6ix

News releases
5 in the last 12 months · 54 in all · newest Nov 16, 2026 · oldest 2021
Decks
6 decks · latest May 22, 2025

Where Instil Bio, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TIL · Home listing · This pageNASDAQUnited StatesUSD
BOATS:TILBOATSUnited StatesUSD
Tradegate:5GT0TradegateGermanyEUR
Frankfurt:5GT0FrankfurtGermanyEUR

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$60.56M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.3×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.8×
Beta vs S&P 500
0.57

Forecasts

1 hold · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
7.00 USD · Analysts' mean
EPS, year to Dec 2026
-2.23 · 1 analyst

Team and board

Officers

OfficerRole
Sandeep Steve LaumasChief Financial Officer & Chief Business Officer

Board

DirectorRole
Bronson CrouchChairman of the Board
George MatchamBoard Member
Gwendolyn BinderBoard Member
Neil GibsonBoard Member
R. Kent McGaughyBoard Member

Events

QuarterResultsShare move
Q3 2026Nov 16, 2026 · Before open−5.4%
Q2 2026Aug 13, 2026 · After close+1.5%
Q1 2026May 15, 2026+1.1%
Q4 2025Mar 27, 2026 · Before open−6.8%
Q3 2025Nov 13, 2025 · Before open−7.2%
Q2 2025Aug 13, 2025 · Before open+0.5%
Q1 2025May 13, 2025 · Before open−6.9%
Q4 2024Mar 19, 2025 · Before open−5.3%
Q3 2024Nov 13, 2024 · Before open−5.5%
Q2 2024Aug 13, 2024 · After close+1.1%
All 20 quarters
QuarterResultsShare move
Q1 2024May 10, 2024 · Before open+3.1%
Q4 2023Mar 21, 2024 · After close−1.5%
Q3 2023Nov 13, 2023 · After close−5.4%
Q2 2023Aug 14, 2023 · Before open−5.2%
Q1 2023May 11, 2023 · Before open−7.4%
Q4 2022Mar 31, 2023 · Before open−0.4%
Q3 2022Nov 14, 2022 · After close+1.2%
Q2 2022Aug 12, 2022 · Before open+2.2%
Q1 2022May 16, 2022 · Before open+8.7%
Q4 2021Mar 7, 2022 · Before open−1.6%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (May 2025)Investor deck18 slidesMay 22, 2025
Corporate Update (March 2025)Corporate update9 slidesMar 4, 2025
Investor Presentation (September 2024)Investor deck12 slidesSep 16, 2024
Investor Presentation (August 2024)Investor deck15 slidesAug 15, 2024
Technical Presentation (June 2023)Technical14 slidesJune 2023
Technical Presentation (April 2021)Technical15 slidesApril 2021

Open Decks

IPO

Priced at US$20.00 a share on Mar 18, 2021.

Price
US$20.00 a share
Shares offered
16,000,000 shares of common stock
Offering size
US$320 million
Underwriters' option
Up to 2,400,000 more shares
Underwriters
MORGAN STANLEY, JEFFERIES, COWEN, TRUIST SECURITIES · In the order on the cover
Shares delivered
On or about Mar 23, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceJan 12, 2021
Filed publiclyFeb 26, 2021
Amended twiceNewest Mar 18, 2021
Shares registered with an exchangeMar 15, 2021
Declared effective by the SECMar 18, 2021
Final prospectus, with the priceMar 22, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Mar 22, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue00000138.0K0
Cost of revenue534.0K3.61M4.76M5.99M2.75M20.0K
Gross profit-534.0K-3.61M-4.76M-5.99M-2.75M138.0K-20.0K
Research and development24.7M11.8M39.6M141.1M107.3M19.4M4.03M
Selling, general and administrative27.2M44.2M47.6M62.2M48.3M14.4M2.56M
Operating income-80.3M-73.5M-159.2M-226.5M-155.6M-33.6M-6.58M
Depreciation and amortization534.0K3.61M4.76M5.99M2.75M256.0K20.0K
EBITDA-79.7M-69.9M-154.4M-220.5M-152.8M-33.4M-6.57M
Interest expense5.96M8.99M5.21M1.88M03.30M0
Income before tax-71.4M-74.1M-156.1M-225.3M-156.8M-37.6M-6.52M
Income tax00-2.07M39.0K151.0K-68.0K
Net income-71.4M-74.1M-156.1M-223.2M-156.8M-37.7M-6.45M
Earnings per share, basic-10.71-11.39-24.00-34.46-1.48-2.36-1.01
Earnings per share, diluted-10.71-11.39-24.00-34.46-1.48-2.36

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents6.64M8.80M9.20M43.7M37.6M241.7M8.89M
Short-term investments69.5M104.5M141.2M217.2M416.5M0
Receivables848.0K2.62M8.14M3.17M
Inventory1.18M
Current assets192.4M124.5M160.8M269.4M464.0M246.1M9.29M
Property, plant and equipment126.0K129.4M138.7M196.9M122.0M55.3M190.0K
Goodwill05.72M5.72M0
Total assets204.5M263.6M325.6M482.1M610.0M319.0M9.48M
Accounts payable779.0K659.0K1.21M2.36M5.57M3.50M979.0K
Current liabilities7.03M7.90M10.6M32.8M41.4M13.3M1.42M
Long-term debt84.8M84.2M81.4M72.3M
Total debt85.2M86.9M86.1M79.9M
Total liabilities91.8M94.1M99.8M118.5M54.8M26.6M1.42M
Shareholders' equity112.7M168.3M225.8M363.6M555.2M-39.6M8.06M
Shares outstanding6.78M6.53M6.50M6.50M129.0M20.6M6.41M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-36.6M-55.7M-82.0M-180.2M-122.1M-29.6M-5.29M
Capital spending-10.0M0-20.7M-84.6M-57.8M-50.8M-760.0K
Free cash flow-36.6M-55.7M-102.7M-264.8M-180.0M-80.4M-6.05M
Cash from investing25.5M54.0M41.1M114.5M-474.4M-51.1M-760.0K
Cash from financing7.29M1.75M8.08M71.9M393.2M313.0M14.9M
Share buybacks393.2M
Change in cash-3.85M33.0K-32.8M6.26M-203.4M232.3M8.89M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
8-K · Current reportNov 16, 2026ResultsSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportAug 13, 2026ResultsSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
4 · Change in ownershipJun 12, 2026Insider tradeSEC
8-K · Current reportJun 11, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 15, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportMay 15, 2026ResultsSEC
ARS · Annual report to shareholdersApr 24, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 24, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 24, 2026Meeting noticeSEC
8-K · Current reportApr 3, 2026Current reportSEC
S-8 · Registration statement for employee plansMar 27, 2026Offer documentSEC
10-K · Annual reportMar 27, 2026Annual reportSEC
8-K · Current reportMar 27, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 9, 2026Big-stake noticeSEC
8-K · Current reportJan 6, 2026Current reportSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 13, 2025ResultsSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
144 · Notice of proposed saleSep 10, 2025Other filingsSEC
10-Q · Quarterly reportAug 13, 2025Quarterly reportSEC
8-K · Current reportAug 13, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
8-K · Current reportJul 31, 2025Current reportSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
8-K · Current reportMay 28, 2025Meeting outcomeSEC
8-K · Current reportMay 27, 2025Current reportSEC
8-K · Current reportMay 22, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
8-K · Current reportMay 13, 2025ResultsSEC
DEFR14AMay 2, 2025Meeting noticeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
4 · Change in ownershipApr 28, 2025Insider tradeSEC
ARS · Annual report to shareholdersApr 14, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 14, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 14, 2025Meeting noticeSEC
424B5 · ProspectusMar 31, 2025Offer documentSEC
8-K · Current reportMar 28, 2025Material contractSEC
S-8 · Registration statement for employee plansMar 4, 2025Offer documentSEC
10-K · Annual reportMar 4, 2025Annual reportSEC
8-K · Current reportMar 4, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
8-K · Current reportJan 14, 2025Current reportSEC
8-K · Current reportDec 23, 2024Material contractSEC
EFFECT · Notice that a registration is effectiveNov 22, 2024Other filingsSEC
CORRESP · Letter to the SECNov 19, 2024Other filingsSEC
UPLOAD · Letter from the SECNov 19, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
S-3 · Registration statementNov 13, 2024Offer documentSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
8-K · Current reportNov 13, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedOct 25, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedOct 22, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeSep 27, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeSep 27, 2024Big-stake noticeSEC
4 · Change in ownershipSep 23, 2024Insider tradeSEC
4 · Change in ownershipSep 23, 2024Insider tradeSEC
8-K · Current reportSep 16, 2024Current reportSEC
8-K · Current reportSep 6, 2024Current reportSEC
8-K · Current reportAug 15, 2024Current reportSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
8-K · Current reportAug 13, 2024ResultsSEC
8-K · Current reportAug 1, 2024Material contractSEC
8-K · Current reportJul 11, 2024Material contractSEC
8-K · Current reportJun 17, 2024Meeting outcomeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
8-K · Current reportMay 10, 2024ResultsSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 26, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 26, 2024Meeting noticeSEC
8-K · Current reportApr 26, 2024Management or board changeSEC
SC 13G · Big-stake noticeApr 2, 2024Big-stake noticeSEC
S-8 · Registration statement for employee plansMar 21, 2024Offer documentSEC
10-K · Annual reportMar 21, 2024Annual reportSEC
8-K · Current reportMar 21, 2024ResultsSEC
8-K · Current reportFeb 14, 2024Management or board changeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
4 · Change in ownershipFeb 13, 2024Insider tradeSEC
8-K · Current reportJan 18, 2024Current reportSEC
8-K · Current reportJan 16, 2024Current reportSEC
4 · Change in ownershipJan 10, 2024Insider tradeSEC
4 · Change in ownershipJan 10, 2024Insider tradeSEC
4 · Change in ownershipJan 10, 2024Insider tradeSEC
4 · Change in ownershipJan 10, 2024Insider tradeSEC
4 · Change in ownershipJan 10, 2024Insider tradeSEC
8-K · Current reportDec 8, 2023Current reportSEC
8-K · Current reportNov 27, 2023Current reportSEC
10-Q/A · Quarterly report, amendedNov 13, 2023Quarterly reportSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
8-K · Current reportNov 13, 2023ResultsSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
8-K · Current reportAug 14, 2023ResultsSEC
8-K · Current reportJun 26, 2023Current reportSEC
8-K · Current reportJun 14, 2023Meeting outcomeSEC
10-Q · Quarterly reportMay 11, 2023Quarterly reportSEC
8-K · Current reportMay 11, 2023ResultsSEC
DEFR14AApr 28, 2023Meeting noticeSEC
ARS · Annual report to shareholdersApr 24, 2023Annual reportSEC
DEFA14A · Additional proxy materialApr 24, 2023Meeting noticeSEC
DEF 14A · Proxy statementApr 24, 2023Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 14, 2023Meeting noticeSEC
SC 13G/A · Big-stake notice, amendedApr 10, 2023Big-stake noticeSEC
10-K · Annual reportMar 31, 2023Annual reportSEC
8-K · Current reportMar 31, 2023ResultsSEC
8-K · Current reportMar 10, 2023Current reportSEC
8-K · Current reportFeb 27, 2023Management or board changeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2023Big-stake noticeSEC
8-K · Current reportFeb 1, 2023Current reportSEC
8-K · Current reportJan 27, 2023Current reportSEC
4/A · Change in ownership, amendedJan 20, 2023Insider tradeSEC
4/A · Change in ownership, amendedJan 20, 2023Insider tradeSEC
4 · Change in ownershipJan 20, 2023Insider tradeSEC
4 · Change in ownershipJan 20, 2023Insider tradeSEC
4 · Change in ownershipJan 20, 2023Insider tradeSEC
8-K · Current reportJan 9, 2023Current reportSEC
8-K · Current reportDec 8, 2022Management or board changeSEC
10-Q · Quarterly reportNov 14, 2022Quarterly reportSEC
8-K · Current reportNov 14, 2022ResultsSEC
8-K · Current reportNov 8, 2022Current reportSEC
8-K · Current reportOct 31, 2022Current reportSEC
8-K · Current reportOct 18, 2022Current reportSEC
4 · Change in ownershipSep 6, 2022Insider tradeSEC
3 · Initial statement of ownershipSep 6, 2022Insider tradeSEC
8-K · Current reportSep 6, 2022Management or board changeSEC
10-Q · Quarterly reportAug 12, 2022Quarterly reportSEC
8-K · Current reportAug 12, 2022ResultsSEC
SC 13G · Big-stake noticeJun 22, 2022Big-stake noticeSEC
8-K · Current reportJun 13, 2022Material contractSEC
8-K · Current reportMay 27, 2022Current reportSEC
4 · Change in ownershipMay 25, 2022Insider tradeSEC
4 · Change in ownershipMay 25, 2022Insider tradeSEC
4 · Change in ownershipMay 25, 2022Insider tradeSEC
4 · Change in ownershipMay 25, 2022Insider tradeSEC
4 · Change in ownershipMay 25, 2022Insider tradeSEC
4 · Change in ownershipMay 25, 2022Insider tradeSEC
8-K · Current reportMay 20, 2022Meeting outcomeSEC
8-K · Current reportMay 18, 2022Current reportSEC
8-K · Current reportMay 16, 2022ResultsSEC
10-Q · Quarterly reportMay 16, 2022Quarterly reportSEC
3 · Initial statement of ownershipMay 3, 2022Insider tradeSEC
S-3ASR · Registration statementApr 1, 2022Offer documentSEC
DEFA14A · Additional proxy materialMar 30, 2022Meeting noticeSEC
DEF 14A · Proxy statementMar 30, 2022Meeting noticeSEC
4 · Change in ownershipMar 17, 2022Insider tradeSEC
4 · Change in ownershipMar 7, 2022Insider tradeSEC
4 · Change in ownershipMar 7, 2022Insider tradeSEC
4 · Change in ownershipMar 7, 2022Insider tradeSEC
4 · Change in ownershipMar 7, 2022Insider tradeSEC
10-K · Annual reportMar 7, 2022Annual reportSEC
8-K · Current reportMar 7, 2022ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2022Big-stake noticeSEC
8-K · Current reportDec 17, 2021Management or board changeSEC
8-K · Current reportNov 15, 2021Current reportSEC
10-Q · Quarterly reportNov 15, 2021Quarterly reportSEC
8-K · Current reportNov 15, 2021Current reportSEC
SC 13G · Big-stake noticeNov 10, 2021Big-stake noticeSEC
4 · Change in ownershipOct 8, 2021Insider tradeSEC
8-K · Current reportSep 16, 2021Current reportSEC
4 · Change in ownershipSep 13, 2021Insider tradeSEC
8-K · Current reportSep 13, 2021Current reportSEC
10-Q · Quarterly reportAug 12, 2021Quarterly reportSEC
8-K · Current reportAug 12, 2021ResultsSEC
4 · Change in ownershipMay 13, 2021Insider tradeSEC
4 · Change in ownershipMay 13, 2021Insider tradeSEC
4 · Change in ownershipMay 13, 2021Insider tradeSEC
4 · Change in ownershipMay 13, 2021Insider tradeSEC
8-K · Current reportMay 13, 2021ResultsSEC
10-Q · Quarterly reportMay 13, 2021Quarterly reportSEC
8-K · Current reportApr 27, 2021Current reportSEC
S-8 · Registration statement for employee plansApr 20, 2021Offer documentSEC
SC 13G · Big-stake noticeApr 15, 2021Big-stake noticeSEC
8-K · Current reportApr 13, 2021Current reportSEC
SC 13D · Big-stake noticeApr 5, 2021Big-stake noticeSEC
SC 13G · Big-stake noticeApr 1, 2021Big-stake noticeSEC
SC 13D · Big-stake noticeApr 1, 2021Big-stake noticeSEC
4 · Change in ownershipMar 25, 2021Insider tradeSEC
4 · Change in ownershipMar 25, 2021Insider tradeSEC
4 · Change in ownershipMar 25, 2021Insider tradeSEC
4 · Change in ownershipMar 25, 2021Insider tradeSEC
4 · Change in ownershipMar 25, 2021Insider tradeSEC
4 · Change in ownershipMar 25, 2021Insider tradeSEC
8-K · Current reportMar 23, 2021Current reportSEC
4 · Change in ownershipMar 22, 2021Insider tradeSEC
4 · Change in ownershipMar 22, 2021Insider tradeSEC
4 · Change in ownershipMar 22, 2021Insider tradeSEC

This page holds 200 of 250 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Instil Bio, Inc.’s releases · as of Aug 11, 2026

Common shares
6,781,976
Fully diluted
6,781,976

Fully diluted

LineSharesAs of
Common shares6,781,976Aug 11, 2026

Share count over time

CountShares
Aug 11, 20266,781,976

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
BML Capital Management, LLC646K9.5%US$4.67MSep 30, 2026
Vivo Capital, LLC293K4.3%US$2.12MSep 30, 2026
UBS230K3.4%US$1.67MSep 30, 2026
Vanguard195K2.9%US$1.41MSep 30, 2026
Millennium104K1.5%US$750KSep 30, 2026
Kalehua Capital Management LLC99,6001.5%US$721KSep 30, 2026
BlackRock54,9200.81%US$398KSep 30, 2026
Nomura50,0000.74%US$362KSep 30, 2026
Geode Capital42,2340.62%US$306KSep 30, 2026
Renaissance Technologies40,3120.59%US$292KSep 30, 2026
All 22 holders
HolderSharesOf the companyValueAs of
Jacobs Levy Equity Management, Inc33,9930.50%US$246KSep 30, 2026
LPL Financial LLC31,1170.46%US$225KSep 30, 2026
Morgan Stanley18,9960.28%US$138KSep 30, 2026
State Street17,5190.26%US$127KSep 30, 2026
Americana Partners, LLC16,1760.24%US$117KSep 30, 2026
Dimensional14,9550.22%US$108KSep 30, 2026
Citadel14,0840.21%US$102KSep 30, 2026
Nuveen1,1050.02%US$7,890Sep 30, 2026
GK Wealth Management LLC502<0.01%US$3,634Sep 30, 2026
Tower Research Capital LLC (TRC)213<0.01%US$1,542Sep 30, 2026
BNP Paribas6<0.01%US$43Sep 30, 2026
Barclays2<0.01%US$14Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund119K1.8%US$915KJun 30, 2026
Nomura Healthcare Fund50,0000.74%US$385KJun 30, 2026
Vanguard Extended Market Index Fund41,5890.61%US$320KJun 30, 2026
Fidelity Extended Market Index Fund22,6890.33%US$183KMay 31, 2026
iShares Micro-Cap ETF12,8490.19%US$98,809Jun 30, 2026
T. Rowe Price Extended Equity Market Index Fund8,7000.13%US$66,903Jun 30, 2026
Avantis U.S. Small Cap Equity ETF7,4920.11%US$60,460May 31, 2026
Fidelity Total Market Index Fund6,7750.10%US$54,674May 31, 2026
Dimensional U.S. Small Cap ETF6,6530.10%US$47,369Jul 31, 2026
Fidelity Series Total Market Index Fund5,3770.08%US$43,392May 31, 2026
All 20 holders
HolderSharesOf the companyValueAs of
Fidelity Nasdaq Composite Index Fund3,2160.05%US$25,953May 31, 2026
Vanguard Balanced Index Fund3,1570.05%US$24,277Jun 30, 2026
Schwab Total Stock Market Index Fund2,9810.04%US$21,225Jul 31, 2026
Dimensional U.S. Core Equity 2 ETF1,3850.02%US$9,861Jul 31, 2026
U.S. Core Equity 1 Portfolio1,0520.02%US$7,490Jul 31, 2026
Dimensional US Sustainability Core 1 ETF1,0000.01%US$7,120Jul 31, 2026
U.S. Social Core Equity 2 Portfolio8060.01%US$5,739Jul 31, 2026
1290 VT Micro Cap Portfolio7260.01%US$5,583Jun 30, 2026
Avantis U.S. Small Cap Equity Fund404<0.01%US$3,260May 31, 2026
State Street Balanced Index Fund76<0.01%US$584Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Timothy L Moore
Other companies: BioLife Solutions, Inc. (Director · Since at least Sep 1, 2022); Cerus Corporation (Director · Since at least Sep 5, 2018); Allogene Therapeutics, Inc. (Chief Technical Officer · Apr 24, 2023 – Feb 3, 2025 · Past); Kite Pharma Inc (EVP, Technical Operations · Mar 15, 2016 – Oct 3, 2017 · Past)
Chief Operating Officer · Sep 6, 2022 – Sep 6, 2022 · Past
Jack Nielsen
Other companies: Aligos Therapeutics, Inc. (Director · Jun 23, 2022 – Feb 27, 2024 · Past); ALX Oncology Holdings Inc. (Director · Jun 15, 2022 – Jun 20, 2023 · Past); Harmony Biosciences Holdings, Inc. (Director · Mar 30, 2022 – May 29, 2024 · Past)
Director · May 20, 2022 – Jun 14, 2023 · Past
John M. Maraganore
Other companies: Beam Therapeutics Inc. (Board Member · Since at least Nov 5, 2026); Rapport Therapeutics, Inc. (Venture Partner, ARCH Venture Partners and Atlas Ventures · Since at least Oct 22, 2026); Alnylam Pharmaceuticals, Inc. (Director · Since at least Mar 3, 2026)
Director · Jun 11, 2025 – Nov 4, 2026 · Past
Neil Gibson
Other companies: Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Jun 1, 2023 · Past); Regulus Therapeutics Inc (Chief Scientific Officer · Oct 4, 2012 – Jan 28, 2015 · Past)
Board Member · Since at least Mar 18, 2021
R Kent McGaughy Jr
Other companies: Apollo Endosurgery Inc (Director · Dec 29, 2016 – Apr 4, 2023 · Past); Reata Pharmaceuticals Inc (Director · May 25, 2016 – Sep 26, 2023 · Past)
Director · Since at least Mar 18, 2021
Gwendolyn Binder
Other companies: Cabaletta Bio, Inc. (President, Science & Technology · Since at least Oct 24, 2019)
Board Member · Since at least Mar 18, 2021
Bronson CrouchChairman of the Board · Since at least Mar 18, 2021
George MatchamBoard Member · Since at least Nov 5, 2026
Jamie FreedmanChief Medical Officer · Jun 2, 2025 – Nov 4, 2026 · Past
R. Kent McGaughyBoard Member · Since at least Nov 5, 2026
All 11 people
PersonSeat
Sandeep Steve LaumasChief Financial Officer & Chief Business Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Instil Bio, Inc.